Emcure Pharmaceuticals

0:16:05

Emcure Pharma IPO Summary | CA Rachana Ranade

0:00:43

Namita Thapar's Emcure Pharma Makes BUMPER #stockmarket Debut, Lists At 31% Premium On NSE

0:01:41

A Day at Emcure | Showcase | hirist.com | iimjobs.com

0:03:14

My Journey at Emcure | Showcase | iimjobs.com

0:00:53

Emcure Pharmaceuticals' Namita Thapar's Inspiring Journey | #WomenWhoGro | #Shorts

0:07:23

Emcure Pharmaceuticals ki Kahaani | Success | Entrepreneur | Shark Tank India 3 | Namita Thapar

0:05:23

Emcure Pharmaceutical Stock Analysis | What's Next for Emcure Pharmaceutical | Angel One

0:11:29

Emcure Pharmaceuticals IPO | Apply or Avoid?

0:01:38

Emcure Pharma Gains After Kotak Instl Equities Upgrades It To Buy With Target Of ₹1,680 | CNBC TV18

0:00:58

Kotak Instl Equities Initiates Coverage On Emcure Pharma With 'Add' Rating; Target Price Of 1,655/Sh

0:01:52

Emcure Pharma Gets a Boost! Kotak's Rating Upgrade Explained

0:01:02

Emcure's EmZindagi for Emcureans

0:01:00

Emcure Pharmaceuticals Limited IPO #ipo #emcure #sharktank

0:00:40

Emcure redefining the boundaries with ‘Cure and Beyond’ featuring MS Dhoni

0:01:32

MS Dhoni and Emcure make a formidable team for Cure and Beyond.

0:04:06

Emcure Pharma IPO: All You Need To Know Before Investing

0:01:46

Ezecure 250 Tablets Benifits Uses In Hindi.

0:01:11

Emcure Pharma Gains After Jefferies Initiates Coverage With Buy Rating & Target Price Of ₹1,600

0:10:41

Emcure Pharmaceuticals IPO Review

0:01:46

Stock Of The Day | Anil Singhvi recommends buying M&M Futures & Emcure Pharma

0:13:20

EMCURE IPO Important RHP Points | Money purse IPO

0:01:30

Emcure Pharma IPO | Anil Singhvi Insights : Long-Term Investors Can hold?

0:16:22

10x Growth Story of Emcure Pharmaceuticals | Shark Tank Judge Ms. Namita Thapar